Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome
2014 ◽
Vol 20
(1)
◽
pp. 111-117
◽
2009 ◽
Vol 18
(12)
◽
pp. 1565-1569
◽
2007 ◽
Vol 13
(4)
◽
pp. 454-462
◽
2007 ◽
Vol 19
(6)
◽
pp. 660-666
◽
2012 ◽
Vol 18
(3)
◽
pp. 473-480
◽
2017 ◽
Vol 23
(3)
◽
pp. S263
2014 ◽
Vol 20
(3)
◽
pp. 425-429
◽
2011 ◽
Vol 17
(3)
◽
pp. 384-393
◽